Edwards Lifesciences Corp/ US28176E1082 /
| 2024-11-19 4:14:34 PM | Chg. -1.06 | Volume | Bid4:14:34 PM | Ask4:14:34 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 68.84USD | -1.51% | 402,983 Turnover: 22.04 mill. |
68.81Bid Size: 200 | 68.86Ask Size: 1,300 | 40.53 bill.USD | - | 29.75 |
Assets
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 442.9000 | 482.5000 | 580 | 679.7000 | 867.5000 | ||||||
| Intangible Assets | 23.4000 | 205.4000 | 204.8000 | 468 | 343.2000 | ||||||
| Long-Term Investments | 240.9000 | 379.9000 | 532.1000 | 567 | 506.3000 | ||||||
| Fixed Assets | 1,229.7000 | 2,011.4000 | 2,270 | 3,163.7000 | 3,036.8000 | ||||||
| Inventories | 296.8000 | 339.9000 | 396.6000 | 554.9000 | 607 | ||||||
| Accounts Receivable | 288 | 315.4000 | 365.5000 | 421.6000 | 456.9000 | ||||||
| Cash and Cash Equivalents | 653.8000 | 718.4000 | 930.1000 | 818.3000 | 714.1000 | ||||||
| Current Assets | 2,294.6000 | 2,047.9000 | 2,240 | 2,532.1000 | 2,286.9000 | ||||||
| Total Assets | 3,524.3000 | 4,059.3000 | 4,510 | 5,695.8000 | 5,323.7000 | ||||||
Liabilities
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 58.2000 | 63.9000 | 97.1000 | 116.6000 | 134 | ||||||
| Long-term debt | 598.1000 | 599.9000 | 822.3000 | 438.4000 | 593.8000 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 376.2000 | 412.3000 | 435.4000 | 636.6000 | 876.6000 | ||||||
| Liabilities | 1,332.9000 | 1,556.2000 | 1,891 | 2,739.6000 | 2,183.3000 | ||||||
| Share Capital | 257.8000 | 717.3000 | 727.8000 | 636 | 645.6000 | ||||||
| Total Equity | 2,191.4000 | 2,503.1000 | 2,619 | 2,956.2000 | 3,140.4000 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 3,524.3000 | 4,059.3000 | 4,510 | 5,695.8000 | 5,323.7000 | ||||||
Income Statement
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 2,322.9000 | 2,493.7000 | 2,963.7000 | 3,435.3000 | 3,722.8000 | ||||||
| Depreciation (total) | 68.6000 | 65.8000 | - | - | - | ||||||
| Operating Result | - | - | - | 1,089.4000 | 748.2000 | ||||||
| Interest Income | 10.8000 | 9.3000 | 8.4000 | 2.9000 | -2.1000 | ||||||
| Income Before Taxes | 1,144 | 622.4000 | 737.9000 | 1,034.9000 | 761.4000 | ||||||
| Income Taxes | 332.9000 | 127.5000 | 168.4000 | 451.3000 | 39.2000 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 811.1000 | 494.9000 | 569.5000 | 583.6000 | 722.2000 | ||||||
Per Share
Cash Flow
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 1,022.3000 | 549.7000 | 704.4000 | 1,000.7000 | 926.8000 | ||||||
| Cash Flow from Investing Activities | -633 | -316.1000 | -211.7000 | -647.2000 | 76.7000 | ||||||
| Cash Flow from Financing | -153 | -158.6000 | -268.5000 | -473.2000 | -1,101.2000 | ||||||
| Decrease / Increase in Cash | 233.4000 | 64.6000 | 211.7000 | -111.8000 | -104.2000 | ||||||
| Employees | 9,100 | 9,800 | 11,100 | 12,200 | 12,800 | ||||||
